Baxter International Inc. is a U.S.-based healthcare company that develops, manufactures, and sells a broad portfolio of hospital and home-care products used in critical care, surgery, and drug delivery. Its offerings include sterile IV solutions, infusion systems, parenteral nutrition therapies, surgical hemostats and sealants, smart beds, patient monitoring technologies, respiratory devices, and injectable pharmaceuticals. The company serves hospitals, dialysis centers, nursing homes, ambulatory surgery centers, doctors’ offices, and patients at home under physician supervision. Baxter operates globally, manufacturing in more than 20 countries and selling in over 100 countries, with its business shaped by healthcare spending, reimbursement, clinical practice, and supply-chain reliability.
6,0 %
30,1 %
−8,5 %
+5,7 %
2.31
1.56
| % | |
|---|---|
| Medical Products & Therapies | 47% Sterile IV solutions, infusion systems, administration sets, parenteral nutrition, and surgical hemostat/sealant products. |
| Healthcare Systems & Technologies | 33% Connected care solutions including smart beds, patient monitoring, diagnostic technologies, respiratory devices, and OR equipment. |
| Pharmaceuticals | 20% Specialty injectable pharmaceuticals, inhaled anesthetics, and drug compounding services. |
Baxter sells primarily to institutional healthcare customers that need essential, recurring-use products in acute and...
Buy Baxter's core IV, infusion, surgical, monitoring, and respiratory products for daily inpatient care and procedures.
Nursing homes and rehabilitation centers purchase therapies and devices used in ongoing patient management.
Buy surgical, diagnostic, and anesthesia-related products for outpatient procedures and office-based care.
Use Baxter therapies and related products for chronic treatment workflows and patient support.
Use selected Baxter therapies that can be administered outside the hospital setting.
Baxter has a broad global footprint, manufacturing products in more than 20 countries and selling in over 100 countries...
Baxter's current strategy is centered on disciplined capital allocation, deleveraging, and selective investment in the...
Debt service constrains flexibility, so deleveraging supports credit quality and future strategic options.
Operational efficiency and supply reliability are critical in essential healthcare products with high service expectations.
Innovation helps defend pricing and relevance in competitive hospital and device markets.
Baxter faces meaningful execution risk from its ongoing strategic actions, including the Kidney Care sale, the BPS...
Divestitures, restructuring, and portfolio changes can create transition costs, dis-synergies, and execution complexity.
Customers focus on cost-effectiveness and healthcare consolidation can increase demands for concessions.
Essential products require reliable production and distribution; disruptions can cause shortages and penalties.
Weak performance or macroeconomic deterioration can reduce fair value below carrying value.
International sales and manufacturing expose Baxter to currency swings, trade rules, and local compliance requirements.
BSX · Surgical & Medical Instruments & Apparatus
Boston Scientific Corporation develops, manufactures, and markets medical devices used across a wide range of interventional specialties.
SYK · Surgical & Medical Instruments & Apparatus
DVA · Services-Misc Health & Allied Services, NEC
DaVita is a kidney-care company built around outpatient dialysis, integrated kidney care management, and related ancillary services.
BDX · Surgical & Medical Instruments & Apparatus
Becton, Dickinson and Company (BD) is a U.S.-based medical technology company with roots dating back to 1897 and incorporation in 1906.
ICUI · Surgical & Medical Instruments & Apparatus
ICU Medical develops, manufactures, and sells medical devices and software used in infusion therapy, vascular access, and critical care settings.
XAIR · Surgical & Medical Instruments & Apparatus
: 11/08/2026